Christopher Ragucci

Christopher Ragucci serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of critical scientific and operational capabilities. He manages a diverse portfolio of contracts focused on laboratory diagnostics, biomedical research equipment, and data infrastructure essential for disease surveillance and rapid public health response. His work directly enables CDC’s scientific operations by securing advanced instrumentation, diagnostic platforms, and specialized research services aligned with national health priorities. Ragucci’s acquisitions span high-complexity technical domains requiring rigorous compliance with federal procurement regulations and lifecycle management of mission-critical assets. He maintains established working relationships with leading providers in the life sciences and public health sectors, including General Dynamics Information Technology, Cepheid, GlaxoSmithKline, MRIGLOBAL, and the New York City Health & Hospitals Corp. These partnerships reflect a preference for proven vendors with demonstrated expertise in deploying diagnostic systems, biosafety-compliant equipment, and epidemiological data solutions. Ragucci’s contracting approach emphasizes vendor reliability, technical scalability, and regulatory adherence, often leveraging indefinite-delivery/indefinite-quantity (IDIQ) and performance-based contract structures to ensure agile response to emerging health threats. His procurement strategy prioritizes open competition, with 83.3% of awards issued without set-asides, reflecting the technical specificity and scale of requirements. However, he consistently allocates 16.7% of opportunities to total small business set-asides under FAR 19.5, demonstrating a measured commitment to small business participation without compromising mission-critical capabilities. His socioeconomic contracting patterns reflect a balanced approach—favoring competition while ensuring equitable access for qualified small businesses in technical fields. Ragucci’s primary procurement focus lies in NAICS 333310 (commercial and service industry machinery) and 333998 (miscellaneous machinery), corresponding to laboratory automation systems and diagnostic hardware. He also actively procures industrial gas systems (325120) and life sciences R&D services (541715), underscoring expertise in biomedical engineering, analytical instrumentation, and public health research infrastructure. His domain knowledge spans biosafety-level environments, clinical diagnostics, and data-enabled surveillance platforms.